"/> Novus Biologicals™ Peptide bloquant d’anticorps IL… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps IL-27R alpha/WSX-1/TCCR

Réf. : BL-RE-085265Réf. fabricant : 18738603 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
9466
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76728. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 16 amino acids near the amino terminus of human TCCR.

Points forts

Source

Synthetic

(Accession #: NP_004834) The IL-27R alpha/WSX-1/TCCR Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-085265
Réf. fabricant18738603
Gene ID (Entrez)9466
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76728. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneclass I cytokine receptor, CRL1IL-27 R, Cytokine receptor-like 1, IL27R, IL-27 RA, IL-27 R-alpha, interleukin 27 receptor, alpha, interleukin-27 receptor subunit alpha, TCCRIL-27 receptor subunit alpha, T-cell cytokine receptor type 1, Type I T-cell cytokine receptor, WSX-1, WS x 1 IL-27 R subunit alpha, zcytor1
Symbole de gène(s)IL27RA
Type de produitIL-27 R alpha/WSX-1/TCCR
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne16 amino acids near the amino terminus of human TCCR
Une question, une configuration particulière ?
Contactez-nous pour un devis.